Elderberry
Sambucus nigra fruit products marketed mainly for respiratory infections. Reviews find a small and heterogeneous evidence base that does not support prevention claims or establish effectiveness for COVID-19.
Pharmacokinetic model
A route-level PK model for elderberry is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review
Systematic review found limited evidence that elderberry might shorten symptoms in some respiratory infections, with no established preventive effect and no direct evidence for COVID-19. Trials were few, small, and…
-
Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial
Trial in air travelers evaluated one proprietary elderberry preparation around travel. Cold incidence was not clearly prevented; secondary duration and symptom findings require replication and cannot generalize to all…
2 published studies referenced in the app, each with a plain-language summary.